Fibre-enriched tapioca pearls cut fat over 12 weeks

Obesity is a growing public health challenge worldwide and is strongly linked to metabolic syndrome, type 2 diabetes and cardiovascular disease, so interventions that people will actually stick with matter as much as ones that work in principle. Inulin, a soluble fermentable fibre derived mainly from Jerusalem artichoke and chicory, has been reported to help with weight management and metabolic health, but it is usually delivered as a powder or capsule. The question here is different and more practical: can a fibre be built into a familiar, palatable carbohydrate food — tapioca pearls, the chewy spheres in bubble tea — and still shift body composition?

This was a randomised, double-blind, placebo-controlled trial in fifty women with a BMI of 27 or above or a waist circumference over 80 cm, aged between 20 and 50 years. Participants were allocated to receive either the inulin-enriched tapioca pearls (branded I-fiber pearl) or a matched placebo, consuming 2 packs per day at 100 g per pack, for 12 weeks. Anthropometric indices, body composition and blood biochemistry were assessed before and after the intervention period. The outcomes of interest spanned both body composition measures and the standard blood lipid panel.

After 12 weeks, the I-fiber group showed significant reductions in body weight, BMI, body fat mass and visceral fat relative to the comparison. The lipid outcomes moved in the same direction, with significant falls in total cholesterol and LDL cholesterol. The authors conclude that the product improved both body composition and lipid profiles, suggesting potential as a functional supplement for obesity management. Notably, the abstract reports statistical significance without giving the magnitude of any of these changes, so the practical scale of the benefit — kilograms lost, centimetres of visceral fat, millimoles of cholesterol — cannot be judged from what is presented.

The result is consistent with the existing literature on soluble fermentable fibre and metabolic health, and its contribution is the delivery format rather than the ingredient. Fortifying a refined-carbohydrate food that people already enjoy is an appealing route to raising fibre intake, and this trial suggests the approach is at least worth testing further. It does not, however, disentangle mechanism: whether the effect comes from fermentation and its downstream metabolic effects, from satiety and reduced intake elsewhere in the diet, or from displacing other foods. Larger trials, mixed-sex samples, longer follow-up and reported effect sizes are all still missing.

This is a reason to think that soluble fibre can be engineered into everyday carbohydrate foods without losing its metabolic effect, which is an encouraging direction for food design. It is not evidence that a specific branded product outperforms simply eating more fibre-rich whole foods, since no such comparison was made. With fifty women in a single 12-week trial, and a commercial affiliation among the authors, the appropriate posture is interest rather than confidence. Anyone reading a headline about visceral fat should also note that the abstract never says how much visceral fat actually changed.'